Ultime notizie per Bit Digital (NASDAQ:BTBT) Azioni

Bit Digital

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

Bit Digital Inc

News

General

USIO

Usio Files For Mixed Shelf Of Up To $37M

WIIM

BCAX

Bicara Therapeutics shares are trading lower after the company announced a publication of phase 1/1b trial data for ficerafusp alfa showing mixed results, with median survival still unreached and limited clarity on long-term efficacy.

Shares of IonQ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) soared on Thursday after CEO Niccolo de Masi made bold statements comparing the company's trajectory <a href="https://www.benzinga.com/content/45540077/how-does-d-wave-stack-up-against-quantum-competitors">to that of Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</a>.
What To Know: The move follows a<a href="https://www.barrons.com/articles/ionq-quantum-computing-nvidia-02c0d4ea"> Barron's interview</a> in which de Masi outlined IonQ's ambitions to dominate the quantum computing sector, asserting the company would be the leader that others imitate.
He told Barron&#8217;s that the company is in the business of quantum &#8220;just like Nvidia&#8221; is in the business of classical GPUs.
Despite <a href="https://www.benzinga.com/news/earnings/25/05/45268901/ionq-q1-earnings-revenue-beat-smaller-than-expected-loss-forward-guidance-and-more">reporting</a> flat first-quarter revenue of $7.57 million at the beginning of May, unchanged from the year prior and down 35% sequentially, the company topped analyst expectations by a small margin. IonQ also reported a narrower quarterly loss of $32.3 million compared to $39.6 million a year earlier. The company also reaffirmed its full-year revenue forecast of $75 million to $95 million.
De Masi emphasized that IonQ is more than just a science experiment, highlighting its complete infrastructure, including manufacturing, customer service, sales and applications teams. He also pointed to recent acquisitions, such as ID Quantique and Lightsync, as well as a partnership with Swedish logistics firm Einride, as signs of expanding global presence and ecosystem development.
Though IonQ shares are up 450% on a one-year basis, the stock had fallen 20% earlier in 2025 following a short-seller report from Kerrisdale Capital accusing the company of overstating its accomplishments. De Masi dismissed the report as baseless and said IonQ would not waste time responding.
Traders are reacting to IonQ's positioning and future-focused messaging. The company&#8217;s pitch, positioning itself as a vital player for major tech firms needing a quantum edge, has reignited the sector on Thursday withs several other quantum names like D-Wave, Rigetti and Quantum Computing also seeing double-digit gains.
Despite no profits and ongoing skepticism around commercialization timelines, sentiment appears to have shifted following the CEO's comments and the company&#8217;s continued stream of partnership and acquisition news. IonQ's market cap now stands around $8.75 billion, the largest among publicly traded quantum players.
IONQ Price Action: <a href="http://benzinga.com/quote/ionq">IonQ shares </a>closed Thursday up 36.8% at $45.89, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/05/45503887/quantum-vs-ai-nvidias-next-big-bet-could-supercharge-these-2-etfs">Quantum Vs AI: Nvidia&#8217;s Next Big Bet Could Supercharge These 2 ETFs</a></li>
</ul>
Image: courtesy of IonQ.

Movers

IONQ

NVDA

IonQ Stock Surges After CEO Suggests Nvidia-Like Future In Quantum Computing Space: What's Going On?

Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) has outperformed the market over the past 20 years by 4.62% on an annualized basis producing an average annual return of 12.87%. Currently, Norfolk Southern has a market capitalization of $54.03 billion. 
Buying $100 In NSC: If an investor had bought $100 of NSC stock 20 years ago, it would be worth $1,126.13 today based on a price of $239.64 for NSC at the time of writing.
<h3>Norfolk Southern's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747948513_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Biotech

ADAG

Adagene Reveals  Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA in Colorectal Cancer At The American Society of Clinical Oncology  Annual Meeting

Bicara Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAX#NASDAQ">BCAX</a>), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the publication of an abstract with updated interim data from the company's Phase 1/1b clinical trial of ficerafusp alfa in combination with pembrolizumab in patients with first line (1L) recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) on the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting website. The company will host a conference call on Sunday, June 1, 2025 at 3:00 p.m. CT / 4:00 p.m. ET to present the fulsome dataset, including overall survival (OS) and duration of response (DOR) data, following an oral presentation of the data at the ASCO Annual Meeting. Ficerafusp alfa is a first-in-class bifunctional antibody designed to enhance tumor penetration by breaking barriers within the tumor microenvironment that have challenged the treatment of multiple solid tumor cancers. Specifically, ficerafusp alfa combines two clinically validated targets: an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-β).

Bicara Therapeutics Announces Publication Of An Abstract With Updated Interim Data From Phase 1/1b Trial Of Ficerafusp alfa In 1L R/M HNSCC At The 2025 ASCO Annual Meeting; Updated Phase 1/1b Data For Ficerafusp Alfa In Head And Neck Cancer Shows Mixed Results, With Median Survival Still Unreached And Limited Clarity On Long-Term Efficacy

BULL

BULL stock has given up its prior loss. Webull shares were trading lower after the company reported Q1 financial results.

REGN

Regeneron Pharmaceuticals Reveals Initial Results From Two Cohorts Of The Phase 1b LINKER-MM2 Trial Evaluating Linvoseltamab In Combination With Two Different Proteasome Inhibitors – Carfilzomib Or Bortezomib – In Patients With Relapsed/Refractory Multiple Myeloma

Webull Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) shares are trading lower in Thursday&#8217;s after-hours session after the company reported first-quarter financial results. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/n45574733/webull-reports-first-quarter-2025-financial-results">of the report</a>.
Q1 Results: Webull reported first-quarter revenue of $117.37 million, up 32% from $88.94 million on a year-over-year basis. The brokerage platform company attributed the revenue increase to strong account growth and increases in trading volumes.
Webull reported a first-quarter loss of six cents per share.
The company said total customer assets grew 45% year-over-year to $12.6 billion at quarter&#8217;s end, driven by strong net deposit growth of 66% year-over-year. Registered users grew 17% year-over-year to 24.1 million and funded accounts jumped 10% to 4.7 million. 
&#8220;We are proud to have delivered a very strong&nbsp;first quarter, driven by significant account and trading volume growth that reflects continued demand for Webull&#8217;s differentiated trading platform,&#8221; said&nbsp;Anthony Denier, group president and U.S. CEO of Webull.
&#8220;We believe our results speak to our strong value proposition, reliable and innovative platform, and focus on global distribution to meet the needs of our sophisticated retail customers. Moving forward we will remain focused on broadening our product portfolio, introducing new asset classes, and expanding access to customers globally.&#8221;
Webull&#8217;s management team will further discuss the quarter on a call with investors and analysts at 5 p.m. ET.
BULL Price Action: <a href="http://benzinga.com/quote/bull">Webull shares</a> were down 2.07% after-hours, trading at $13.22 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45575402/intuit-q3-earnings-revenue-beat-eps-beat-raised-fy-guidance-company-seeing-exceptional-momentum-across-platforms">Intuit Q3 Earnings: Revenue Beat, EPS Beat, Raised FY Guidance, Company Seeing &#8216;Exceptional&#8217; Momentum Across Platforms</a></li>
</ul>
Photo: gguy/Shutterstock.

Earnings

After-Hours Center

Webull Reports Q1 Earnings, Shares Slide

TALO

Talos Energy Files For Mixed Shelf; Size Not Disclosed - Sec Filing

<h3>Gainers</h3>
<ul>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) stock moved upwards by 49.5% to $0.2 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million. </li>
<li>VS Media Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) shares rose 7.74% to $0.85. The company's market cap stands at $8.0 million. </li>
<li>MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) stock rose 4.92% to $10.66. The company's market cap stands at $591.1 million. </li>
<li>Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) stock increased by 3.65% to $0.17. The company's market cap stands at $4.1 million. </li>
<li>WideOpenWest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOW#NYSE">WOW</a>) stock rose 3.59% to $4.32. The market value of their outstanding shares is at $369.2 million. </li>
<li>iHeartMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IHRT#NASDAQ">IHRT</a>) stock moved upwards by 3.22% to $1.28. The company's market cap stands at $188.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Gamehaus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMHS#NASDAQ">GMHS</a>) shares fell 7.0% to $1.33 during Thursday's after-market session. The company's market cap stands at $71.2 million. </li>
<li>Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) shares fell 6.31% to $12.19. The company's market cap stands at $192.2 million. </li>
<li>Token Cat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TC#NASDAQ">TC</a>) shares decreased by 6.16% to $0.73. The market value of their outstanding shares is at $2.2 million. </li>
<li>Arena Group Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AREN#AMEX">AREN</a>) shares decreased by 5.52% to $7.37. The company's market cap stands at $350.5 million. </li>
<li>E W Scripps (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) shares decreased by 3.8% to $2.03. The market value of their outstanding shares is at $177.7 million. </li>
<li>EPWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) shares declined by 3.3% to $8.66. The company's market cap stands at $193.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AREN

ASST

BLMZ

EPWK

GMHS

IHRT

VSME

12 Communication Services Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Tiziana Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSA#NASDAQ">TLSA</a>) shares increased by 10.2% to $1.51 during Thursday's after-market session. The company's market cap stands at $176.4 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) shares rose 9.58% to $0.39. The market value of their outstanding shares is at $57.1 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) stock moved upwards by 7.95% to $2.85. The company's market cap stands at $2.1 million. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) stock moved upwards by 7.67% to $0.68. The company's market cap stands at $22.8 million. </li>
<li>Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) stock moved upwards by 7.43% to $0.45. The market value of their outstanding shares is at $6.5 million. </li>
<li>Prime Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) stock rose 7.31% to $1.32. The company's market cap stands at $173.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Outlook Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>) shares declined by 21.4% to $1.29 during Thursday's after-market session. The company's market cap stands at $43.3 million. </li>
<li>ImmuCell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCC#NASDAQ">ICCC</a>) shares fell 16.67% to $5.15. The company's market cap stands at $46.5 million. </li>
<li>Gyre Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GYRE#NASDAQ">GYRE</a>) shares fell 15.35% to $9.49. The market value of their outstanding shares is at $836.0 million. </li>
<li>Immix Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMX#NASDAQ">IMMX</a>) shares decreased by 12.08% to $2.12. The market value of their outstanding shares is at $59.0 million. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) shares declined by 11.52% to $1.23. The company's market cap stands at $3.1 million. </li>
<li>Cibus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBUS#NASDAQ">CBUS</a>) shares fell 8.84% to $2.53. The market value of their outstanding shares is at $82.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BDRX

BDSX

CBUS

GYRE

ICCC

IMMX

IMNN

NIVF

OTLK

PRME

RANI

TLSA

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) shares moved upwards by 26.4% to $3.78 during Thursday's after-market session. The company's market cap stands at $13.5 million. </li>
<li>Decent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXST#NASDAQ">DXST</a>) stock rose 9.16% to $1.31. The market value of their outstanding shares is at $21.2 million. </li>
<li>Smart Powerr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREG#NASDAQ">CREG</a>) shares increased by 8.73% to $0.74. The company's market cap stands at $18.1 million. </li>
<li>FTAI Infrastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIP#NASDAQ">FIP</a>) shares rose 6.99% to $5.35. The company's market cap stands at $613.9 million. </li>
<li>Rain Enhancement (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIN#NASDAQ">RAIN</a>) shares moved upwards by 6.88% to $4.66. The company's market cap stands at $35.3 million. </li>
<li>Freight Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) shares moved upwards by 6.23% to $0.74. The market value of their outstanding shares is at $1.6 million. The company's, Q1 earnings came out 4 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares decreased by 8.0% to $0.52 during Thursday's after-market session. The market value of their outstanding shares is at $3.6 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) stock fell 6.15% to $6.57. The market value of their outstanding shares is at $11.2 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) shares fell 5.71% to $5.13. The market value of their outstanding shares is at $433.7 million. </li>
<li>Corporacion America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAAP#NYSE">CAAP</a>) shares fell 5.71% to $20.5. The company's market cap stands at $3.3 billion. The company's, Q1 earnings came out today. </li>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) stock fell 5.34% to $0.15. The company's market cap stands at $4.6 million. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) shares decreased by 4.72% to $0.6. The market value of their outstanding shares is at $3.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATXG

CAAP

CREG

DXST

EVTL

FRGT

GPUS

RAIN

SGBX

VCIG

VSTE

12 Industrials Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares moved upwards by 21.6% to $3.55 during Thursday's after-market session. The market value of their outstanding shares is at $5.3 million. </li>
<li>Expensify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXFY#NASDAQ">EXFY</a>) stock increased by 11.11% to $2.6. The market value of their outstanding shares is at $240.2 million. </li>
<li>Mobilicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOB#NASDAQ">MOB</a>) stock increased by 8.55% to $1.65. The company's market cap stands at $12.3 million. </li>
<li>Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) shares increased by 8.22% to $720.84. The company's market cap stands at $201.5 billion. As per the news, the Q3 earnings report came out today. </li>
<li>Nukkleus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) stock rose 6.64% to $21.35. The company's market cap stands at $107.3 million. </li>
<li>Lantronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRX#NASDAQ">LTRX</a>) stock increased by 4.91% to $2.35. The company's market cap stands at $91.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock declined by 7.1% to $0.58 during Thursday's after-market session. The company's market cap stands at $1.1 million. </li>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) shares declined by 6.7% to $2.51. The market value of their outstanding shares is at $151.5 million. The company's, Q1 earnings came out today. </li>
<li>Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) stock fell 6.0% to $255.75. The market value of their outstanding shares is at $68.4 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Xerox Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>) shares fell 5.86% to $4.82. The market value of their outstanding shares is at $606.3 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock decreased by 5.65% to $0.58. The company's market cap stands at $4.1 million. </li>
<li>Viasat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) shares fell 4.57% to $9.62. The market value of their outstanding shares is at $1.2 billion. The company's, Q4 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EXFY

INTU

LTRX

MOVE

NUKK

SOBR

VSAT

WDAY

12 Information Technology Stocks Moving In Thursday's After-Market Session

VSTM

Verastem Reveals Updated Results From Ramp 205 Evaluating Avutometinib Plus Defactinib In Combination With Standard-Of-Care Chemotherapy In Frontline Metastatic Pancreatic Ductal Adenocarcinoma

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Morgan Stanley Direct (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSDL#NYSE">MSDL</a>) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Morgan Stanley Direct, revealing an average target of $20.29, a high estimate of $22.00, and a low estimate of $19.00. Experiencing a 3.7% decline, the current average is now lower than the previous average price target of $21.07. 
<img src="https://www.benzinga.com/files/images/story/2025/1747947686_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Morgan Stanley Direct. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$21.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Finian O'Shea</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Melissa Wedel</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$19.50</td>
<td>$20.50</td>
</tr>
<tr>
<td>Doug Harter</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$20.50</td>
<td>$21.00</td>
</tr>
<tr>
<td>Ryan Lynch</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$20.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Finian O'Shea</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$21.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Morgan Stanley Direct. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Morgan Stanley Direct compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Morgan Stanley Direct's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Morgan Stanley Direct's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MSDL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Morgan Stanley Direct analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Morgan Stanley Direct</h2>
Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.
<h3>Morgan Stanley Direct: Delving into Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, Morgan Stanley Direct faced challenges, resulting in a decline of approximately -36.6% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 94.91%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Morgan Stanley Direct's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.62%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Morgan Stanley Direct's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.76%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.11, Morgan Stanley Direct adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

MSDL

Demystifying Morgan Stanley Direct: Insights From 7 Analyst Reviews

6 analysts have expressed a variety of opinions on iRhythm Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $143.5, along with a high estimate of $167.00 and a low estimate of $124.00. This current average has increased by 15.1% from the previous average price target of $124.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1747947675_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A clear picture of iRhythm Technologies's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joanne Wuensch</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$167.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>William Plovanic</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$139.00</td>
<td>$152.00</td>
</tr>
<tr>
<td>Nathan Treybeck</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Mike Polark</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$150.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>David Saxon</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$151.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>David Roman</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$124.00</td>
<td>$91.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to iRhythm Technologies. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of iRhythm Technologies compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of iRhythm Technologies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into iRhythm Technologies's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IRTC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on iRhythm Technologies analyst ratings.</a>
<h2>Unveiling the Story Behind iRhythm Technologies</h2>
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
<h3>Breaking Down iRhythm Technologies's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: iRhythm Technologies displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 20.27%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: iRhythm Technologies's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -19.35%, the company may face hurdles in effective cost management.
Return on Equity (ROE): iRhythm Technologies's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -34.58%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): iRhythm Technologies's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -3.31%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 8.49, iRhythm Technologies faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IRTC

Demystifying iRhythm Technologies: Insights From 6 Analyst Reviews

UGG and HOKA brand parent company Deckers Outdoor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) reported fourth-quarter financial results for fiscal 2025 after the market close on Thursday. Here&#8217;s a look at the key highlights <a href="https://www.benzinga.com/pressreleases/25/05/b45574243/deckers-brands-reports-fourth-quarter-and-full-fiscal-year-2025-financial-results">from the period</a>.
Q4 Earnings: Deckers reported fourth-quarter revenue of $1.02 billion, beating analyst&nbsp;<a href="http://benzinga.com/quote/DECK/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $1.01 billion. The casual footwear and apparel company reported fourth-quarter earnings of $1 per share, beating analyst estimates of 59 cents per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue increased 6.5% year-over-year. Direct-to-consumer sales were down 1.2% to $410.2 million while wholesale net sales increased 12.3% to $611.6 million. Here&#8217;s a breakdown of revenue by brand:
<ul class="wp-block-list">
<li>UGG brand revenue: $374.3 million, up 3.6%</li>
</ul>
<ul class="wp-block-list">
<li>HOKA brand revenue: $586.1 million, up 10%</li>
</ul>
<ul class="wp-block-list">
<li>Other brands revenue: $61.3 million, down 6.3%</li>
</ul>
Deckers Outdoor ended the quarter with inventories of $495.2 million and $1.89 billion in cash and cash equivalents.
&#8220;While the global trade environment has introduced greater near-term uncertainty, we are very confident in the exciting opportunities ahead for HOKA and UGG,&#8221; said Stefano Caroti, president and CEO of Deckers Outdoor.
&#8220;We view these brands as industry leaders, each with iconic and innovative products that operate in differentiated marketplaces. Alongside Deckers&#8217; superb balance sheet, this positions us well to manage through the near-term with a focus on the long-term.&#8221;
Deckers repurchased $266 million of its common stock in the fourth quarter, and subsequently purchased another $84 million after the quarter&#8217;s end. The company&#8217;s board approved an increase of $2.25 billion to its buyback program, bringing the total authorization up to approximately $2.5 billion.
Deckers also announced that it appointed Cynthia Davis as board chair, effective immediately. Davis will replace Michael Devine, who is retiring after 14 years. 
Guidance: Deckers expects first-quarter revenue of $890 million to $910 million versus estimates of $925.86 million. The company anticipates first-quarter earnings of 62 cents to 67 cents per share versus estimates of 81 cents per share. 
Deckers also noted that it is holding back full-year guidance, citing &#8220;macroeconomic uncertainty related to evolving global trade policies.&#8221;
The soft guidance and cautious full-year approach appears to be weighing on shares after hours. Management is currently discussing the quarter on a conference call that started at 4:30 p.m. ET.
DECK Price Action: Deckers Outdoor shares were down 13.63% after-hours, trading at $108.90 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45575045/workday-shares-slide-after-q1-results-q2-reveue-guidance-below-estimates">Workday Shares Slide After Q1 Results, Q2 Reveue Guidance Below Estimates</a></li>
</ul>
Photo: Delovely Pics/Shutterstock.

Guidance

Buybacks

DECK

UGG, HOKA Parent Deckers Outdoor Issues Soft Q1 Guidance, Holds Back FY26 Outlook Due To 'Macroeconomic Uncertainty,' Shares Tumble Despite Bigger Buyback Plans

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4434208-1&amp;h=3287040409&amp;u=https%3A%2F%2Fwww.weyerhaeuser.com%2F&amp;a=Weyerhaeuser+Company">Weyerhaeuser Company</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>) today announced an agreement to acquire approximately 117,000 acres of high-quality timberlands in North Carolina and Virginia from Roanoke Timberlands LLC, a subsidiary of Roseburg Forest Products, for $375 million. Comprised of mature, highly productive timberlands, the acreage will be well-integrated with existing Weyerhaeuser timberland and mill operations in North Carolina, will expand the company's footprint into attractive markets in southeastern Virginia and will offer substantial alternative value opportunities. The acquisition is expected to deliver immediate and sustained portfolio-leading cash flows within the company's Southern Timberlands business.

Weyerhaeuser To Acquire 117,000 Acres Of Timberlands In North Carolina And Virginia For $375M, Expanding Southern Footprint And Boosting Cash Flows

Across the recent three months, 6 analysts have shared their insights on Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $9.5, with a high estimate of $12.00 and a low estimate of $7.00. This current average has decreased by 18.1% from the previous average price target of $11.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1747947662_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Applied Digital. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Miller</td>
<td>JMP Securities</td>
<td>Announces</td>
<td>Market Outperform</td>
<td>$12.00</td>
<td>-</td>
</tr>
<tr>
<td>John Todaro</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$10.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Brett Knoblauch</td>
<td>Cantor Fitzgerald</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$7.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>John Todaro</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$10.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Kevin Dede</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$7.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>John Todaro</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Applied Digital. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Applied Digital compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Applied Digital's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Applied Digital's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/APLD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Applied Digital analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Applied Digital</h2>
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments; Data Center Hosting Business, Cloud Services Business, and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business which operates data centers to provide energized space to crypto mining customers.
<h3>Financial Milestones: Applied Digital's Journey</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Applied Digital's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 22.08% as of 28 February, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Applied Digital's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -68.21%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -8.12%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Applied Digital's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -2.22%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Applied Digital's debt-to-equity ratio is below the industry average. With a ratio of 2.19, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APLD

Analyst Expectations For Applied Digital's Future

Press Releases

Bit Digital, Inc. Announces Monthly Production Update for January 2025

Bit Digital, Inc. Secures New Multi-Year Colocation Agreement with a Leader in AI Hardware

Soluna (SLNH) and Bit Digital (BTBT) Partnership Expands, Surpassing 12 MW in Hosting Capacity

Bit Digital, Inc. Announces Date for Fiscal Year 2024 Financial Results and Conference Call

Cerebras Announces Six New AI Datacenters Across North America and Europe to Deliver Industry's Largest Dedicated AI Inference Cloud

Bit Digital, Inc. Announces Fiscal Year 2024 Financial Results

WhiteFiber and Shadeform Announce Strategic Partnership to deliver on-demand access to NVIDIA B200 GPUs

Bit Digital, Inc. Secures Site for New Tier 3 Data Center to Support Cerebras Colocation Contract

Bit Digital, Inc. Announces Date for First Quarter 2025 Financial Results and Conference Call

Bit Digital, Inc. Announces First Quarter of Fiscal Year 2025 Financial Results

BTBT

SLNH

Agora

Digital Turbine

Arqit Quantum

Blend Labs

Consensus Cloud Solutions, Inc. - Common Stock

Consensus Cloud Solns

Cerence

Daily Journal Corp. (S.C.) - Common Stock

Daily Journal

Domo

E2open Parent Holdings, Inc.Class A Common Stock

E2open Parent Holdings

BitFuFu

AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A Ordinary Shares)

AMTD Digital

i3 Verticals

Kaltura

Mercurity Fintech Holding Inc. - American Ordinary Shares

Mercurity Fintech Holding

Mitek Systems

Next Technology Holding Inc. - Ordinary Shares

Next Technology Holding

Ooma

Pros Holdings

Red Violet

Rimini Street

Riskified

ReposiTrak

Weave Communications

Xunlei Limited - American Depositary Shares

Xunlei

Yext

HC Wainwright & Co.

Craig-Hallum

B. Riley Securities

Northland Capital Markets

BITF

BTCT

BTDR

CLSK

CNCK

COIN

HIVE

MARA

MSTR

RIOT

Shares of crypto-linked stocks and Bitcoin miners are trading higher after Bitcoin reached a new all-time high, rising above $110,000.

Comments

Bit Digital

Notizie

Ultime notizie per Bit Digital (NASDAQ:BTBT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO